Investment in Associates and Investments in Investees (Details) - Schedule of Fair Value of the Investment - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
Jun. 30, 2023	Dec. 31, 2022
Schedule of Fair Value of the Investment [Abstract]
Balance at January 1, 2022	$ 591
Investment date March 31, 2022	400	700
Equity losses from investment in MitoCareX		(109)
Balance at December 31, 2022	$ 893	$ 591

The amount of financial assets that are measured at fair value through other comprehensive income. A financial asset shall be measured at fair value through other comprehensive income if both of the following conditions are met: (a) the financial asset is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets and (b) the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. [Refer: At fair value [member]; Financial assets]

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 8
-Subparagraph h
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8_h&doctype=Standard
-URIDate 2023-03-23

Name:	ifrs-full_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant